In this study, we used the plant-based N. benthamiana ΔXT/FT expression platform to produce neutralizing mucosal IgA antibodies against SARS-CoV-2, performed a detailed biochemical and functional analysis of the recombinant antibodies, and explored their potential use to prevent infection in an in vivo model. The gene discussed is CD79A; the disease is infection.